ST segment elevation myocardial infarction

Rajat Deo; Christopher P. Cannon; James A de Lemos

doi:10.1007/978-1-59259-918-9_27

ST segment elevation myocardial infarction

Rajat Deo, Christopher P. Cannon, James A de Lemos

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

Management of acute ST elevation myocardial infarction (STEMI) has been transformed in the last 20 yr by the results of large, prospective, randomized trials. Advances have been made in all components of acute myocardial infarction (AMI) management, from primary and secondary prevention to prehospital care, acute reperfusion therapy, adjunctive medical therapy, and management of complications. Despite this progress, however, acute MI remains the most common cause of death in industrialized nations; in addition, while mortality rates have been falling, the incidence of new infarction has not fallen in concert. The long-term consequences of myocardial infarction, congestive heart failure and ventricular arrhythmias, consume a large and growing proportion of health care resources. Thus, there is great need for continued progress in the prevention and treatment of acute MI.

Original language	English (US)
Title of host publication	Essential Cardiology
Subtitle of host publication	Principles and Practice: Second Edition
Publisher	Humana Press
Pages	489-520
Number of pages	32
ISBN (Print)	158829370X, 9781588293701
DOIs	https://doi.org/10.1007/978-1-59259-918-9_27
State	Published - Dec 1 2006

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-1-59259-918-9_27

Cite this

@inbook{2ece81fa69de461c820a6e7af6f14c18,

title = "ST segment elevation myocardial infarction",

abstract = "Management of acute ST elevation myocardial infarction (STEMI) has been transformed in the last 20 yr by the results of large, prospective, randomized trials. Advances have been made in all components of acute myocardial infarction (AMI) management, from primary and secondary prevention to prehospital care, acute reperfusion therapy, adjunctive medical therapy, and management of complications. Despite this progress, however, acute MI remains the most common cause of death in industrialized nations; in addition, while mortality rates have been falling, the incidence of new infarction has not fallen in concert. The long-term consequences of myocardial infarction, congestive heart failure and ventricular arrhythmias, consume a large and growing proportion of health care resources. Thus, there is great need for continued progress in the prevention and treatment of acute MI.",

author = "Rajat Deo and Cannon, {Christopher P.} and {de Lemos}, {James A}",

year = "2006",

month = dec,

day = "1",

doi = "10.1007/978-1-59259-918-9_27",

language = "English (US)",

isbn = "158829370X",

pages = "489--520",

booktitle = "Essential Cardiology",

publisher = "Humana Press",

}

TY - CHAP

T1 - ST segment elevation myocardial infarction

AU - Deo, Rajat

AU - Cannon, Christopher P.

AU - de Lemos, James A

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Management of acute ST elevation myocardial infarction (STEMI) has been transformed in the last 20 yr by the results of large, prospective, randomized trials. Advances have been made in all components of acute myocardial infarction (AMI) management, from primary and secondary prevention to prehospital care, acute reperfusion therapy, adjunctive medical therapy, and management of complications. Despite this progress, however, acute MI remains the most common cause of death in industrialized nations; in addition, while mortality rates have been falling, the incidence of new infarction has not fallen in concert. The long-term consequences of myocardial infarction, congestive heart failure and ventricular arrhythmias, consume a large and growing proportion of health care resources. Thus, there is great need for continued progress in the prevention and treatment of acute MI.

AB - Management of acute ST elevation myocardial infarction (STEMI) has been transformed in the last 20 yr by the results of large, prospective, randomized trials. Advances have been made in all components of acute myocardial infarction (AMI) management, from primary and secondary prevention to prehospital care, acute reperfusion therapy, adjunctive medical therapy, and management of complications. Despite this progress, however, acute MI remains the most common cause of death in industrialized nations; in addition, while mortality rates have been falling, the incidence of new infarction has not fallen in concert. The long-term consequences of myocardial infarction, congestive heart failure and ventricular arrhythmias, consume a large and growing proportion of health care resources. Thus, there is great need for continued progress in the prevention and treatment of acute MI.

UR - http://www.scopus.com/inward/record.url?scp=84891380496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891380496&partnerID=8YFLogxK

U2 - 10.1007/978-1-59259-918-9_27

DO - 10.1007/978-1-59259-918-9_27

M3 - Chapter

AN - SCOPUS:84891380496

SN - 158829370X

SN - 9781588293701

SP - 489

EP - 520

BT - Essential Cardiology

PB - Humana Press

ER -

ST segment elevation myocardial infarction

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this